The Serologic Prevalence of SARS-CoV-2 amongst Incarcerated Persons in Provincial Correctional Facilities in Saskatchewan

Overview

Acronym
SHA
Investigators
  • Dr. Alexander Wong

    Saskatchewan Health Authority

Contacts
  • Dennaye Fuchs

    Saskatchewan Health Authority

General Design

Study design
Cross-sectional
Start Year
2021
Recruitment Target
  • Individuals
Number of Participants
400
Number of Participants with Biological Samples
400

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Population

SHA population

Selection Criteria

Countries
  • Canada
Territory
Saskatchewan
Health Status
  • Exclusion criteria: Anyone in isolation with active SARS-CoV-2 or or under investigation for COVID-19 as a close contact of a diagnosed case; and/or anyone with symptoms compatible with COVID-19.
Other Criteria

Inclusion criteria: Incarcerated at a facility for more than 24 hours; and the ability to understand and consent to study participation.

Exclusion criteria: Anyone posing a security risk to the research team, as determined by correctional officers.

Sources of Recruitment

Specific Population
  • Other specific population : Incarcerated adult male and female
Supplementary Information
Participants were recruited from two selected detention facilities in Regina: Regina Provincial Correctional Centre and White Birch Female Remand Unit.

Sample Size

Number of Participants
400
Number of Participants with Biological Samples
400

Data Collection Events

# Name Description Start End
0 SHA - Baseline 2021 (April) 2021 (July)

Individual Studies Included

Acronym Name Study design Participants Countries

Harmonization Projects Included

Acronym Name

Networks

Acronym Name Studies

Datasets

Name Type Data Collection Events Variables
Last Update: 2021-07-30 15:58